Based upon a successful engagement with the US Food and Drug Administration (FDA) at the End-of-Phase 2 meeting in January 2025, Atea is initiating a global Phase 3 program and expects patient ...

When an organ is injured, our body initiates a healing process. If the injury is repeated or chronic, it can lead to an ...

Sarepta Therapeutics shares dropped 20% after a patient's death raises Elevidys safety concerns. Read why I am downgrading ...

Understanding liver fibrosis progression through machine learning provides valuable insights into disease mechanisms, ...

VANCOUVER, Washington, March 18, 2025 (GLOBE NEWSWIRE) -- Dear Shareholders, ...

Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical development programs focusing on organ fibrosis, today announced financial results ...

OrganOx, maker of a device to preserve liver donations, has teamed up with ProCure On-Demand, an organ recovery services ...

Developed by ancient Greek thinkers in the 5th century BCE, the theory of the four humors continued to develop during the ...

Alabama is the only state where 4th-grade math scores are higher now than they were in 2019, before the pandemic. This is the ...

The drug candidate was tested in a cell culture and a mouse model for MASLD, showing more powerful effects compared to previous senolytics. It selectively targeted senescent liver cells ...